Abbvie Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other
companies in this sector in the United States:
sales of $20.41 billion
of which 34%
Teva Pharmaceutical Industries Limited
of which 49%
was Generic Madicines), and
Eli Lilly and Company
of which 35%
During the year ended December of 2015, sales at
Abbvie Inc were $22.86 billion.
increase of 14.5%
versus 2014, when the company's sales were $19.96 billion.
This was the fifth consecutive year of sales increases at Abbvie Inc
(and since 2010, sales have increased a total of 46%).